These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 25982210)

  • 1. Long-term (>8 years) evaluation of progression in patients with low-pressure glaucoma.
    Erdem E; Williams A; Kuchar SD; Waisbourd M; Spaeth GL
    Eur J Ophthalmol; 2015; 25(6):490-5. PubMed ID: 25982210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of focal lamina cribrosa defect on glaucomatous visual field progression.
    Faridi OS; Park SC; Kabadi R; Su D; De Moraes CG; Liebmann JM; Ritch R
    Ophthalmology; 2014 Aug; 121(8):1524-30. PubMed ID: 24697910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors for visual field progression in treated glaucoma.
    De Moraes CG; Juthani VJ; Liebmann JM; Teng CC; Tello C; Susanna R; Ritch R
    Arch Ophthalmol; 2011 May; 129(5):562-8. PubMed ID: 21555607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the Progression of High- and Low-tension Glaucoma as Determined by Two Different Criteria.
    Lee JY; Sung KR; Lee JY
    Korean J Ophthalmol; 2016 Feb; 30(1):40-7. PubMed ID: 26865802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors affecting rates of visual field progression in glaucoma patients with optic disc hemorrhage.
    Prata TS; De Moraes CG; Teng CC; Tello C; Ritch R; Liebmann JM
    Ophthalmology; 2010 Jan; 117(1):24-9. PubMed ID: 19896197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relationship between the mean deviation slope and follow-up intraocular pressure in open-angle glaucoma patients.
    Fukuchi T; Yoshino T; Sawada H; Seki M; Togano T; Tanaka T; Ueda J; Abe H
    J Glaucoma; 2013 Dec; 22(9):689-97. PubMed ID: 23722866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors and long term progression in open angle glaucoma patients.
    Pantalon AD; Feraru C; Chiseliţă D
    Rom J Ophthalmol; 2016; 60(3):174-180. PubMed ID: 29450344
    [No Abstract]   [Full Text] [Related]  

  • 8. Visual and structural prognosis of the untreated fellow eyes of unilateral normal tension glaucoma patients.
    Cho HK; Suh W; Kee C
    Graefes Arch Clin Exp Ophthalmol; 2015 Sep; 253(9):1547-55. PubMed ID: 26126583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progression of visual field defects in eyes with different optic disc appearances in patients with normal tension glaucoma.
    Nakazawa T; Shimura M; Ryu M; Himori N; Nitta F; Omodaka K; Doi H; Yasui T; Fuse N; Nishida K
    J Glaucoma; 2012 Aug; 21(6):426-30. PubMed ID: 22314251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preperimetric normal tension glaucoma study: long-term clinical course and effect of therapeutic lowering of intraocular pressure.
    Jeong JH; Park KH; Jeoung JW; Kim DM
    Acta Ophthalmol; 2014 May; 92(3):e185-93. PubMed ID: 24456145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-Term Follow-Up of Normal Tension Glaucoma Patients With TBK1 Gene Mutations in One Large Pedigree.
    Quist TS; Johnson CA; Robin AL; Fingert JH
    Am J Ophthalmol; 2020 Jun; 214():52-62. PubMed ID: 31987900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significance of corneal biomechanical properties in patients with progressive normal-tension glaucoma.
    Park JH; Jun RM; Choi KR
    Br J Ophthalmol; 2015 Jun; 99(6):746-51. PubMed ID: 25555704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intraocular pressure fluctuation a risk factor for visual field progression at low intraocular pressures in the advanced glaucoma intervention study.
    Caprioli J; Coleman AL
    Ophthalmology; 2008 Jul; 115(7):1123-1129.e3. PubMed ID: 18082889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beta-Zone parapapillary atrophy and the velocity of glaucoma progression.
    Teng CC; De Moraes CG; Prata TS; Tello C; Ritch R; Liebmann JM
    Ophthalmology; 2010 May; 117(5):909-15. PubMed ID: 20132988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Visual field progression differences between normal-tension and exfoliative high-tension glaucoma.
    Ahrlich KG; De Moraes CG; Teng CC; Prata TS; Tello C; Ritch R; Liebmann JM
    Invest Ophthalmol Vis Sci; 2010 Mar; 51(3):1458-63. PubMed ID: 20042657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characteristics of visual field progression in medically treated normal-tension glaucoma patients with unstable ocular perfusion pressure.
    Sung KR; Cho JW; Lee S; Yun SC; Choi J; Na JH; Lee Y; Kook MS
    Invest Ophthalmol Vis Sci; 2011 Feb; 52(2):737-43. PubMed ID: 20861474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progression detection capability of macular thickness in advanced glaucomatous eyes.
    Sung KR; Sun JH; Na JH; Lee JY; Lee Y
    Ophthalmology; 2012 Feb; 119(2):308-13. PubMed ID: 22182800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optic disc progression and rates of visual field change in treated glaucoma.
    De Moraes CG; Liebmann JM; Park SC; Teng CC; Nemiroff J; Tello C; Ritch R
    Acta Ophthalmol; 2013 Mar; 91(2):e86-91. PubMed ID: 23356423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of Long-Term Visual Field Fluctuation in Glaucoma Patients.
    Rabiolo A; Morales E; Kim JH; Afifi AA; Yu F; Nouri-Mahdavi K; Caprioli J
    Ophthalmology; 2020 Jun; 127(6):739-747. PubMed ID: 31952885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors Associated with Loss of Visual Function in Medically Treated Advanced Normal Tension Glaucoma.
    Kim S; Sung KR
    Curr Eye Res; 2017 Mar; 42(3):429-435. PubMed ID: 27420769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.